| Item |
|
1/17/2011: Koronis Pharmaceuticals - Clinical Trial Results Demonstrate Promise for First Non-suppressive HIV Drug
PHV 1.18.2011 | link | |
|
9/9/2010: Koronis Pharmaceuticals Announces Late-Breaker Oral Presentation on HIV Therapeutic Candidate KP-1461
PHV 11.8.2010 | link | |
|
9/1/2010: 2010 & Beyond: A look at forthcoming new HIV meds and novel ways that treatment could advance over the coming decade.
PHV 9.23.2010 | link | |
|
|
10/28/2009: Novocell is the Recipient of a Disease Team Award for $20 Million from the California Institute for Regenerative Medicine to Develop a Stem Cell Therapy for the Treatment of Diabetes
PHV 10.30.2009 | link | |
|
9/28/2009: Koronis Pharmaceuticals Launches VDA Compendium™
PHV 9.28.2009 | link | |
|
7/31/2009: Need for Novel Approaches to Treating HIV Still Exists (Koronis)
PHV 7.31.2009 | link | |
|
7/13/2009: New glaucoma treatment could provide permanent relief
PHV 7.14.2009 | link | |
|
5/19/2009: Koronis Pharmaceuticals' Scientific Advisory Board Confirms KP-1461 Clinical Drug Activity, HIV Ablation
PHV 5.19.2009 | link | |
|
05/11/2009: Novocell Names John West Chief Executive Officer
PHV 5.14.2009 | link | |
|
05/06/2009: Novocell Receives Grant Awards from California Institute for Regenerative Medicine for Stem Cell Therapy Development
PHV 5.14.2009 | link | |
|
2/09/2009: HIV Mutates to Death With New Drug
PHV 2.10.2009 | link | |
|
11/25/2008: Novocell CEO to Head Juvenile Diabetes Research Foundation (JDRF)
PHV 2.9.2009 | link | |
|
12/22/2008: TransMolecular Receives Orphan Drug Designation for 131I-TM601
PHV 2.9.2009 | link | |
|
12/9/2008: Novocell Announces Collaboration with World-Renowned Stem Cell Researcher
PHV 2.9.2009 | link | |
|
12/19/2008: Novocell Announces Non-Exclusive Drug Discovery Collaboration with Pfizer
PHV 2.9.2009 | link | |
|
|
9/29/2008: Dosing Initiated in TransMolecular’s Phase 1/2 Clinical Trial
PHV 11.5.2008 | link | |
|
9/30/2008: Koronis Pharmaceuticals Announces Appointment of Prominent HIV Researcher Courtney Fletcher, Pharm. D., to Scientific Advisory Board and Jeff Parkins as VP, Clinical Development
PHV 10.28.2008 | link | |
|
9/17/2008: Novocell Awarded Landmark U.S. Patents for Innovative Stem Cell Technologies
PHV 10.27.2008 | link | |
|
6/9/2008: Novocell's Emmanuel Baetge, Ph.D., Featured in Forbes cover story: “Stem Cells Get Real”
PHV 7.1.2008 | link | |
|
6/15/2008: Today’s biopharma venture capital challenge: Risk-sharing models versus risk avoidance
PHV 7.1.2008 | link | |
|
2/21/2008:NY Times-Stem Cell Therapy Controls Diabetes in Mice
PHV 2.21.2008 | link | |
|
|
|
10/17/2007: Seattle Times-Cubist gets option to acquire Illumigen
PHV 10.17.2007 | link | |
|
10/16/2007: Cubist Pharmaceuticals Announces Exclusive Option to Acquire Illumigen Biosciences
PHV 10.16.2007 | link | |
|
9/25/2007: New Kind of Antiretroviral, KP-1461; Clinical Trial Recruiting. Interview with Stephen Becker, M.D.
PHV 9.25.2007 | link | |
|
8/10/2007: Fierce Biotech-Emerging Drug Developers: Koronis Pharmaceuticals
PHV 9.25.2007 | link | |
|
7/16/2007: Novocell Raises $25 Million
PHV 7.25.2007 | link | |
|
6/28/2007: Koronis Pharmaceuticals Raises $20 Million
PHV 7.3.2007 | link | |
|
6/26/2007: Koronis Pharmaceuticals Begins Phase 2a Proof of Concept Study of KP-1461
PHV 7.3.2007 | link | |
|
12/21/2006: Argos Therapeutics Appoints Dr. John Bonfiglio Chief Executive Officer
PHV 1.11.2007 | link | |
|
10/27/2006: Argos Therapeutics Awarded NIH Contract to Further Develop HIV Immunotherapy Candidates
PHV 10.30.2006 | link | |
|
10/19/2006: Novocell Announces Creation of Insulin-Producing Pancreatic Endocrine Cells
PHV 10.20.2006 | link | |
|
8/17/2006: Argos Therapeutics Initiates Phase I/II Trial with AGS-003
PHV 8.22.2006 | link | |
|
7/28/2006: Transmolecular: Version of Scorpion Venom Delivers Radioactive Iodine
PHV 8.22.2006 | link | |
|
|
|
|
10/12/2005: Koronis Pharmaceuticals Begins Phase 1b Clinical Trial
PHV 10.12.2005 | link | |
|
